Previous Page  12 / 27 Next Page
Information
Show Menu
Previous Page 12 / 27 Next Page
Page Background

allied

academies

Page 49

Notes:

June 06-07, 2019 | London, UK

2

nd

International Conference on

Tissue Science and Molecular Biology,

Stem Cells & Separation Techniques

Joint Event

Biomedical Research (An International Journal of Medical Sciences) | ISSN: 0976-1683 Volume 30

Therapeutic potential of primitive mesenchymal stem cells to treat degenerative

diseases

G Rasul Chaudhry

Oakland University, USA

P

erinatal tissues are non-invasive, abundant and rather

primitive sources of mesenchymal stem cells (MSCs) in

comparison to MSCs isolated from adult tissues. They have

received increasing attention since they do not pose ethical

or moral concerns. We have developed a robust, reproducible

and high yielding method for isolation of highly proliferative

MSCs fromumbilical cord/placenta tissue.MSCs isolated from

all other sources stop growing after a few passages. However,

irrespective of the source, all MSCs exhibit fibroblastoid

morphology, express CD29

+

, CD44

+

, CD73

+

, CD90

+

and

CD105

+

and differentiate into adipogenic, chondrogenic and

osteogenic lineages and some into neural lineage as well.

However, the cord/placenta MSCs display higher colony

forming efficiency and express even some pluripotent genes.

They can also be maintained for self-renewal and potency for

extended period of time; therefore, we call them primitive

MSCs. We have investigated the therapeutic potential of

these primitiveMSCs to treat degenerative diseases including

degenerative disc disease (DDD) and retinal degenerative

disease (RDD) using animal models. When MSCs and their

chondrogenic derivatives were injected into the IVDs of

a rabbit model of DDD, they significantly improved the

histology, cellularity, extracellular matrix protein and

water and glycosaminoglycan contents. The IVDs receiving

chondroprogenitor or nucleus pulposus (NP) like cells derived

fromMSCs exhibitedhigher expressionof NP specificmarkers.

The transplanted cells were functionally active in rabbit IVDs

as they expressed human genes and proteins, SOX9, ACAN,

COL2, FOXF1, KRT19, PAX6, CA12 and COMP implicated in NP

biosynthesis. These studies suggested involvement of TGFβ1

pathway in regulating NP regeneration in rabbit IVD. Likewise,

primitive MSCs and their neural derivatives have shown

efficacy to improve vision in rd12mice, amodel of RDD. Latest

findings of these translational studies as well as challenges

and new opportunities will be discussed in the presentation.

e

:

chaudhry@oakland.edu

Biomed Res, Volume 30

ISSN: 0976-1683